Latest news and articles about RemeGen
Total: 1 articles found
China’s 2026 National Essential Medicine List expansion marks a historic shift by including domestic Class I innovative drugs in bulk for the first time. This move leverages hospital performance quotas to force a 'green channel' for high-end biotech products into grassroots and public medical institutions.
